The phase 2 trial for type 2 diabetes used similar starting doses to the obesity trial, with gradual titration
280.060.8 vs 75.449.7 mol/L, p=0.02 and 226.858.5 vs 27.846.1 mol/L, p=0.02 for SAR425899 vs Placebo and 24-h FatOx, -hydroxybutyrate and acetoacetic acid, respectively
Patients should report serious side effects to their provider and to FDA MedWatch (1-800-FDA-1088 or www.fda.gov/medwatch)
Nails grow faster and may feel stronger, a secondary indicator of systemic collagen metabolism improvement
[DOI] [PubMed] [Google Scholar] Yan J., Xie W., Jin Y., Cai Z., Lin Z
These injections are a compounded treatment consisting of two key components: Tirzepatide : A cutting-edge medication originally developed to treat Type 2 diabetes, now being used with great success for weight loss due to its powerful appetite-suppressing and metabolic benefits